ALDH1A3
Basic information
Region (hg38): 15:100861924-100916626
Previous symbols: [ "ALDH6" ]
Links
Phenotypes
GenCC
Source:
- isolated microphthalmia 8 (Strong), mode of inheritance: AR
- isolated microphthalmia 8 (Strong), mode of inheritance: AR
- isolated anophthalmia-microphthalmia syndrome (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Microphthalmia, isolated 8 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic; Ophthalmologic | 23312594 |
ClinVar
This is a list of variants' phenotypes submitted to
- Isolated microphthalmia 8 (5 variants)
- Isolated anophthalmia-microphthalmia syndrome (2 variants)
- not provided (1 variants)
- Microphthalmia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALDH1A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 23 | 28 | ||||
missense | 22 | 35 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 4 | 2 | 7 | ||
non coding | 16 | 26 | 42 | |||
Total | 8 | 8 | 24 | 42 | 32 |
Highest pathogenic variant AF is 0.0000131
Variants in ALDH1A3
This is a list of pathogenic ClinVar variants found in the ALDH1A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-100879560-T-A | Benign (Aug 03, 2018) | |||
15-100879582-G-A | Benign (Nov 10, 2018) | |||
15-100879640-G-A | Benign (Aug 03, 2018) | |||
15-100879926-G-C | Inborn genetic diseases | Uncertain significance (May 17, 2023) | ||
15-100879933-A-T | Inborn genetic diseases | Uncertain significance (Aug 08, 2023) | ||
15-100879950-A-G | Isolated microphthalmia 8 • ALDH1A3-related disorder | Benign/Likely benign (Dec 26, 2023) | ||
15-100880013-C-A | ALDH1A3-related disorder | Likely benign (May 08, 2019) | ||
15-100880021-C-T | Isolated microphthalmia 8 | Likely benign (Mar 28, 2023) | ||
15-100880135-G-A | Likely benign (Jul 01, 2022) | |||
15-100880138-C-G | Likely benign (Jul 01, 2022) | |||
15-100885138-G-A | Likely benign (Dec 09, 2018) | |||
15-100885265-A-G | Isolated microphthalmia 8 | Pathogenic (Sep 01, 2022) | ||
15-100885290-C-G | Isolated microphthalmia 8 • ALDH1A3-related disorder | Likely benign (Dec 12, 2022) | ||
15-100885292-A-C | Inborn genetic diseases | Uncertain significance (Mar 19, 2024) | ||
15-100885337-G-A | Inborn genetic diseases | Uncertain significance (Dec 08, 2023) | ||
15-100885351-G-T | Likely pathogenic (Dec 01, 2016) | |||
15-100885376-A-C | Isolated microphthalmia 8 | Benign (Jan 09, 2023) | ||
15-100885414-G-T | Benign (Mar 06, 2019) | |||
15-100885498-T-C | Benign (Jun 19, 2018) | |||
15-100885522-G-A | Likely benign (Dec 09, 2018) | |||
15-100885655-C-CT | Benign (Sep 01, 2020) | |||
15-100885655-C-CTT | Benign (Jun 18, 2021) | |||
15-100887320-GTCAAAAGATGACACCCAAACTGCAGTCACCTCAAAAGATGACACCCAAACTGCAGTCACC-G | Likely benign (Sep 11, 2018) | |||
15-100887380-C-G | Likely benign (Sep 11, 2018) | |||
15-100887396-G-C | Likely benign (Aug 14, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALDH1A3 | protein_coding | protein_coding | ENST00000329841 | 13 | 38913 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.141 | 0.859 | 125733 | 0 | 15 | 125748 | 0.0000596 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.24 | 192 | 301 | 0.637 | 0.0000180 | 3324 |
Missense in Polyphen | 72 | 145.35 | 0.49537 | 1536 | ||
Synonymous | 0.0733 | 122 | 123 | 0.992 | 0.00000828 | 1020 |
Loss of Function | 3.31 | 6 | 23.2 | 0.259 | 9.79e-7 | 306 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000299 | 0.0000299 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000536 | 0.0000527 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000983 | 0.0000980 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: NAD-dependent aldehyde dehydrogenase that catalyzes the formation of retinoic acid (PubMed:27759097). Has high activity with all-trans retinal, and has much lower in vitro activity with acetaldehyde (PubMed:27759097). Required for the biosynthesis of normal levels of retinoic acid in the embryonic ocular and nasal regions; retinoic acid is required for normal embryonic development of the eye and the nasal region (By similarity). {ECO:0000250|UniProtKB:Q9JHW9, ECO:0000269|PubMed:27759097}.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);beta-Alanine metabolism - Homo sapiens (human);Phenylalanine metabolism - Homo sapiens (human);Histidine metabolism - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Tyrosine metabolism - Homo sapiens (human);Ethanol effects on histone modifications;Vitamin A and Carotenoid Metabolism;Signal Transduction;RA biosynthesis pathway;Phenylalanine degradation;retinoate biosynthesis I;Signaling by Retinoic Acid;Signaling by Nuclear Receptors;Tyrosine metabolism;Histidine degradation
(Consensus)
Recessive Scores
- pRec
- 0.268
Intolerance Scores
- loftool
- 0.606
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.72
Haploinsufficiency Scores
- pHI
- 0.257
- hipred
- Y
- hipred_score
- 0.738
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.715
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Aldh1a3
- Phenotype
- renal/urinary system phenotype; skeleton phenotype; vision/eye phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; respiratory system phenotype; embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- aldh1a3
- Affected structure
- eye
- Phenotype tag
- abnormal
- Phenotype quality
- decreased size
Gene ontology
- Biological process
- optic cup morphogenesis involved in camera-type eye development;retinoic acid biosynthetic process;locomotory behavior;nucleus accumbens development;embryonic camera-type eye development;inner ear morphogenesis;retinol metabolic process;retinoic acid metabolic process;retinal metabolic process;positive regulation of apoptotic process;embryonic eye morphogenesis;neuromuscular process controlling balance;protein homotetramerization;oxidation-reduction process;righting reflex;olfactory pit development;face development;Harderian gland development
- Cellular component
- nucleus;cytoplasm;cytosol;plasma membrane;extracellular exosome
- Molecular function
- retinal dehydrogenase activity;aldehyde dehydrogenase (NAD) activity;aldehyde dehydrogenase [NAD(P)+] activity;protein homodimerization activity;thyroid hormone binding;NAD+ binding